223 related articles for article (PubMed ID: 31048561)
1. Host CYP27A1 expression is essential for ovarian cancer progression.
He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER
Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561
[TBL] [Abstract][Full Text] [Related]
2. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
[TBL] [Abstract][Full Text] [Related]
3. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
[TBL] [Abstract][Full Text] [Related]
4. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol.
Wang X; Zhong F; Chen T; Wang H; Wang W; Jin H; Li C; Guo X; Liu Y; Zhang Y; Li B
Cell Mol Life Sci; 2024 May; 81(1):226. PubMed ID: 38775844
[TBL] [Abstract][Full Text] [Related]
6. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.
Bieghs V; Hendrikx T; van Gorp PJ; Verheyen F; Guichot YD; Walenbergh SM; Jeurissen ML; Gijbels M; Rensen SS; Bast A; Plat J; Kalhan SC; Koek GH; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
Gastroenterology; 2013 Jan; 144(1):167-178.e1. PubMed ID: 23041327
[TBL] [Abstract][Full Text] [Related]
7. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
[TBL] [Abstract][Full Text] [Related]
8. CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis.
Liang Z; Chen Y; Wang L; Li D; Yang X; Ma G; Wang Y; Li Y; Zhao H; Liang Y; Niu H
Cell Cycle; 2019 Jan; 18(1):34-45. PubMed ID: 30563407
[TBL] [Abstract][Full Text] [Related]
9. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
Ma L; Cho W; Nelson ER
Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice.
Hendrikx T; Jeurissen ML; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Houben T; Guichot YD; Gijbels MJ; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
J Hepatol; 2015 Feb; 62(2):430-6. PubMed ID: 25281859
[TBL] [Abstract][Full Text] [Related]
12. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression.
Baek AE; Krawczynska N; Das Gupta A; Dvoretskiy SV; You S; Park J; Deng YH; Sorrells JE; Smith BP; Ma L; Nelson AT; McDowell HB; Sprenger A; Henn MA; Madak-Erdogan Z; Kong H; Boppart SA; Boppart MD; Nelson ER
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33959755
[TBL] [Abstract][Full Text] [Related]
13. CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.
Alfaqih MA; Nelson ER; Liu W; Safi R; Jasper JS; Macias E; Geradts J; Thompson JW; Dubois LG; Freeman MR; Chang CY; Chi JT; McDonnell DP; Freedland SJ
Cancer Res; 2017 Apr; 77(7):1662-1673. PubMed ID: 28130224
[TBL] [Abstract][Full Text] [Related]
14. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
[TBL] [Abstract][Full Text] [Related]
15. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines.
Woo SY; Lee H; Park SM; Choi HS; Kim J; Kwon M; Sohn J; Nam JH; Kim HS; Song P; Baryawno N; Kim YH; Kim K; Lee D
Cell Death Dis; 2022 Oct; 13(10):916. PubMed ID: 36316327
[TBL] [Abstract][Full Text] [Related]
16. De novo synthesis of steroids and oxysterols in adipocytes.
Li J; Daly E; Campioli E; Wabitsch M; Papadopoulos V
J Biol Chem; 2014 Jan; 289(2):747-64. PubMed ID: 24280213
[TBL] [Abstract][Full Text] [Related]
17. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S
Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848
[TBL] [Abstract][Full Text] [Related]
18. The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK
Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332
[TBL] [Abstract][Full Text] [Related]
19. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
[TBL] [Abstract][Full Text] [Related]
20. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
